Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/22/2003CN1450997A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450996A 2-guanidino-4-aryl-quinazoline
10/22/2003CN1450995A 5-hydroxy indazole derivatives for treating glaucoma
10/22/2003CN1450994A 6-Hydroxy-indazole derivatives for treating glaucoma
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1450992A Piperazine derivatives used as CCR5 antagonists
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1450923A Method and compositions for administering taxanes orally to human patients
10/22/2003CN1450914A Preparation of aqueous clear solution dosage forms with bile acids
10/22/2003CN1450913A Combination use of bisphosphonates, estrogenic agents and optionally estrogens
10/22/2003CN1450912A CD40 antagonists for use in treating psoriasis and other inflammatory skin conditions
10/22/2003CN1450905A Method for improving the cell protection
10/22/2003CN1450904A Use of ribose to prevent cramping and soreness in muscles
10/22/2003CN1450903A Processes for preparing clarithromycin polymorphs
10/22/2003CN1450902A Medicinal composition composed of metformin and glyburide
10/22/2003CN1450901A The use of cocoa procyanidins combined with acetylsalic acid as an anti-platelet therapy
10/22/2003CN1450900A Antitumor agents
10/22/2003CN1450899A Bile secretion promoting composition
10/22/2003CN1450898A Compounds for treating fibromyalgia and chronic fatigue syndrome
10/22/2003CN1450897A 5HT2 agonists for controlling IOP and treating glaucoma
10/22/2003CN1450896A Use of indole derivatives for intracular pressure for reducing
10/22/2003CN1450895A Pharmaceutical compositions of estrogenic agents
10/22/2003CN1450894A Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use
10/22/2003CN1450893A Method for treatment of sepsis
10/22/2003CN1450892A Mesoprogestins (progesterone receptor modulators) for treatment and prevention of hormone dependent gynecological
10/22/2003CN1450891A Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base
10/22/2003CN1450890A Novel compositions of minoxidil
10/22/2003CN1450883A Transdermal delivery system for alkaloids of aconitum species
10/22/2003CN1450882A Transdermal administration of huperzine
10/22/2003CN1450077A Method for extracting polygonum cuspidatum tannic acid
10/22/2003CN1450075A Group No.1 oligose and sulfated products, their preparation process and medicine composition containing said oligose
10/22/2003CN1450066A Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant
10/22/2003CN1450032A Compound with base skeleton of 1,6-methylene-[10]-annulene and use thereof
10/22/2003CN1449834A Use of 2-hydroxypropyl beta-cyclodextrin in preparing sodium new houttuy fonate injection
10/22/2003CN1449819A Weishengli oral liquid medicine and preparation process thereof
10/22/2003CN1449816A Pharmaceutics for regulating blood-lipid and protecting liver and preparation process thereof
10/22/2003CN1449796A Capsule containing ginkgo leaf extract
10/22/2003CN1449784A Compound Zedoary Turmeric oil preparation and process for making same
10/22/2003CN1449766A Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof
10/22/2003CN1449765A Puerarin soft capsule pharmaceutics and preparation process thereof
10/22/2003CN1449764A Roxithromycin slow-released pharmaceutics and preparation process thereof
10/22/2003CN1449763A Soy daidzin composition and preparation process and use thereof
10/22/2003CN1449762A Application of scutellarin composition in preparing medicine for preventing and treating diabetes complication
10/22/2003CN1449761A Medicine for relieving spasm and pain and preparation process thereof
10/22/2003CN1449760A Composition of danazol semisolid skeleton preparation
10/22/2003CN1449759A Prostaglandin E1 liposome frozen dry powder injection and production technology thereof
10/22/2003CN1449758A Oral compound slow-released pharmaceutics containing theine and salmol active constituent and preparation process thereof
10/22/2003CN1449757A Domperidone oral disintegrating tablet and preparation process thereof
10/22/2003CN1449756A Difenidol Hydrochloride oral disintegrating tablet and preparation process thereof
10/22/2003CN1449755A Dextromethorphan hydrobromide drop pills and preparation process thereof
10/22/2003CN1449754A Edaravone medicine composition and preparation thereof
10/22/2003CN1449753A Chlorogenic acid and isochlorogenic acid composition and medical use thereof
10/22/2003CN1449752A Cantharidin total anhydride pharmaceutics for treating and preventing SARS and preparation thereof
10/22/2003CN1449751A Use of dicaffeoylquinic acid derivative and analogs in treating disease related to coronavirus infection
10/22/2003CN1449750A Gabapentin slow -released composition
10/22/2003CN1449749A Medicine for treating beriberi and preparation process thereof
10/22/2003CN1449748A Dry powder microsphere inhalant for lung and preparation process thereof
10/22/2003CN1449745A Coated solid hyponotic
10/22/2003CN1449744A Antifungal agent and preparation and use method
10/22/2003CN1449743A Medicinal aerosol and preparation process thereof
10/22/2003CN1449741A 栓塞材料 Embolic material
10/22/2003CN1125174C Recombinant phages
10/22/2003CN1125145C Stable aqueous dispersions and stable water-dispersible dry powders of xanthophylls and production and use of the same
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CN1125079C Cyclopeptolides
10/22/2003CN1125077C Sulphamate derivatives of 1,3,5(10)-estratriene derivatives methods of producing them and pharmaceutical compounds containing them
10/22/2003CN1125076C New process for preparation of azithromycin
10/22/2003CN1125073C Process for preparing (-) pyridobenzoxazine carboxylic acid derviatives
10/22/2003CN1125070C Pyrrolo [2,3-d] pyrmidine compounds, and compositions and use thereof
10/22/2003CN1125068C Process for prodn. of purine derivatives
10/22/2003CN1125067C Crystalline antifungal polymorph
10/22/2003CN1125066C Tetrahydrofuran phosphate-and hydroxy esters as prodrugs for corresponding antifungal agent
10/22/2003CN1125065C Benzo[g] quinoline derivatives
10/22/2003CN1125064C 3-pyridyl enantiomers and their use as analgesics
10/22/2003CN1125062C Dihydrobenzofuran and related compounds useful useful as anti-inflammatory agents
10/22/2003CN1125061C C2 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125060C C-10 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125058C Crystalline dibentothiazepine derivatives and its use as antipsychotic agent
10/22/2003CN1125054C Novel imidazolidine derivatives, their preparation their use and pharmaceutical preparations comprising them
10/22/2003CN1125052C Substituted isoquinoline derivatives and their use as anticonvulsants
10/22/2003CN1125051C Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/22/2003CN1125050C Metalloproteinase inhibitors
10/22/2003CN1125049C New crystal modification N of torasemide
10/22/2003CN1125047C Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy) ethylamino]-2-propanole process for its preparation and pharmaceutical use
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/22/2003CN1125040C Therapeutic compound-fatty acid conjugates
10/22/2003CN1124877C Solid and semi-solid hydrocarbon gels and use thereof
10/22/2003CN1124855C Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and verterinary medical field
10/22/2003CN1124853C Ointment for treating protrusion of lumber intervertebral disc and its preparation
10/22/2003CN1124849C Nail health disinfecting liquid
10/22/2003CN1124848C Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri
10/22/2003CN1124847C Method for treating excessive aggression
10/22/2003CN1124846C (N.N')-bis (sulfonyl) hydrazines useful as antineoplastic agents
10/22/2003CN1124845C Proopofol microdroplet formulations
10/22/2003CN1124843C Stable glassy state powder formulations
10/22/2003CN1124841C Cosmetic skin lightening product for topical application
10/22/2003CA2424577A1 Use of huntingtin and related compounds for modulating cell survival
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
1 ... 5304 5305 5306 5307 5308 5309 5310 5311 5312 5313 5314 5315 5316 5317 5318 5319 5320 5321 5322 5323 5324 ... 7860